B. Mennecier (Strasbourg, France), R. Rami Porta (Barcelona, Spain)
Characteristics of nonsmoker lung cancer patients
E. Sulu, L. Y. Tuncer, E. Damadoglu, S. Arinc, M. Ertugrul, C. Tahaoglu, A. Yilmaz (Istanbul, Turkey)
|  |
Clinical and radiological features of adenocarcinoma cases in accordance with their smoking history
G. Ak, M. Metintas, S. Metintas, H. Yildirim, S. Erginel, E. Kurt, F. Alatas, I. Ucgun (Eskisehir, Turkey)
| |
Survival in 138 patients with non small cell lung cancer (NSCLC) treated with platinum together with gemcitabine or vinorelbine by a multidisciplinary team. Comparison with the Big Lung Trial
R. Varma, S. Sunkaraneni, V. Eades, M. Sekar, S. Patel, J. R. Webb, D. Landau, T. C. Stokes (Woolwich, London, United Kingdom)
| |
Weekly administration of gemcitabine in outpatient clinic for the patients with recurrent non-small cell lung cancer after pulmonary resection
M. Mitsuoka, T. Sakuragi, S. Tomimitsu, H. Kawasaki, T. Ito (Saga, Japan)
| |
A phase II trial in patients with extensive disease small-cell lung cancer with irinotecan, carboplatin and etoposide regimen as a first line treatment
A. G. Charpidou, E. Kosmas, F. Vlastos, N. Vasilopoulos, K. N. Syrigos, C. Bitsakou, C. Roussos (Athens, Greece)
| |
Clinical experience on EGFR tyrosin kinase inhibitor in non-small-cell lung cancer, compassionate programme in the Czech Republic
M. Pesek, J. Skrickova, V. Kolek, P. Zatloukal, A. Svobodnik, L. Petruzelka (Plzen, Brno, Olomouc, Praha, Czech Republic)
| |
The clinicofunctional features of patients with lung cancer and secondary inflammatory changes
Y. N. Shanin, O. B. Ilina, I. M. Kuznetsov (St.-Petersburg, Russian Federation)
| |
Surgical morbidity and mortality in lung cancer patients with idiopathic pulmonary fibrosis
K. Kushibe, T. Kawaguchi, T. Tojo, M. Takahama, M. Kimura, S. Taniguchi (Kashihara, Japan)
| |
Sleep disturbances, daytime functioning and quality of life in patients with lung cancer
Y. Le Guen, F. Gagnadoux, J. Hureaux, T. Jeanfaivre, N. Meslier, J. L. Racineux, T. Urban (Angers, France)
| |
Bone marrow metastases in non-small cell lung cancer patients – a role of flow cytometry
E. Radzikowska, M. Szolkowska, D. Giedronowicz, D. Gawryluk, J. Grudny, J. Zych, K. Roszkowski (Warsaw, Poland)
| |
Neuroendocrine differentiation in non-small cell lung cancer. A biochemical, immunohistological and ultrastructural evaluation of Chromogranin A
S. Sørhaug, S. Steinshamn, R. Haaverstad, H. Waldum (Trondheim, Norway)
| |
Lymphocytic pleural effusion. Can ADA levels in pleural fluid exclude malignancy?
A. Hernando Sanz, E. Perez Rodriguez, F. Troncoso Acevedo, R. Gomez Garcia, M. Valle Falcones, S. Diaz Lobato, E. Manas, R. Light (Madrid, Spain; Nashville, United States Of America)
| |
Cytological diagnosis of malignant mesothelioma – improvement by additional determination of hyaluronic acid in pleural effusions
L. Welker, M. Müller, O. Holz, R. A. Jörres, H. Magnussen (Großhansdorf, Itzehoe, Munich, Germany)
| |
Small bore catheter versus large bore chest tubes for treatment of malignant pleural effusions
C. V. Mitrofan, A. Aldea, C. E. Mitrofan, C. Grigorescu, C. Lovin (Iasi, Romania)
| |
Combination of argon plasma coagulation and photodynamic therapy in thoracoscopic pleurodesis
V. N. Klimenko, A. I. Arsenyev, M. L. Gelfond, A. S. Barchuk, V. G. Lemekhov (Saint-Petersburg, Russian Federation)
| |
Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma
G. Kirbas, A. Abakay, A. Senyigit, O. Abakay (Diyarbakir, Turkey)
| |
Diagnostic value of Ki-67 and repp 86 in distinction between benign and malignant mesothelial proliferations
Z. Mohammadtaheri, M. Mehrafza, F. Mohammadi, S. Karimi, M. Bahadori, M. Masjedi (Tehran, Islamic Republic Of Iran)
| |
Comparison of bronchial washing, brushing and biopsy in 939 cases in cardiothoracic centre (Liverpool)
K. Maleki, M. Ledson (Chester, Liverpool, United Kingdom)
| |
Integrated FDG-PET/CT for improved T and N staging of non-small-cell lung cancer
S. Krueger, A. Buck, S. Pauls, G. Halter, C. Schumann, C. Kropf, F. Mottaghy, V. Hombach, S. Reske (Ulm, Germany)
| |
An optimal minimally-invasive approach to mediastinal lymphadenopathy
K. L. Khoo, K. Y. Ho, K. Christopher, B. Nilsson, T. K. Lim (Singapore, Singapore)
| |